An FDA-approved medication already used to treat people who have type 2 diabetes and chronic kidney disease may also help ...

A multimodal, digital community-based intervention was feasible and decreased illness-related distress in treating patients ...

Pulmonary Artery Pressure Monitoring Falls Short, New Diuretic Insights Emerge Oak Ridge, TN, Feb. 19, 2025 (GLOBE NEWSWIRE) ...

While conducting the study, the researchers tracked data from more than 10,000 patients who presented with type 2 diabetes, ...

Sotagliflozin, recently approved by the FDA for treating type 2 diabetes and kidney disease in patients with cardiovascular ...

You're reaching for your keys in the parking lot after a doctor's visit when it hits you, "What did my physician say I wasn't ...

the MBA/MPH for public health professionals, and the MBA in combination with our surgical residency, for surgeons-in-training. Contact the School of Management for more information about these ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with ...

Sotagliflozin, a drug recently approved by the Food and Drug Administration to treat type 2 diabetes and kidney disease with additional cardiovascular risk factors, can significantly reduce heart ...

A new report from OpenAI shows that students in places like Wyoming could be left behind when it comes to obtaining AI skills ...

Our 49-credit Part-Time MBA program boasts a modern and relevant curriculum, so you can build your degree around the skills needed to advance your career in an industry that inspires you. It provides ...